SCHEMBL1496573

SCHEMBL1496573

CCCCC(O)COc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
CYP2D6 P10635 2/20 0.54
ADRB2 P07550 1/20 0.54
ADRB1 P08588 1/20 0.54
ADRB3 P13945 1/20 0.54
POLB P06746 1/20 0.54
TSHR P16473 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.50
PLA2G4B P0C869 1/20 0.50
LTA4H P09960 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 1/20 0.49
OPRM1 P35372 1/20 0.49
OPRD1 P41143 1/20 0.49
KDM4E B2RXH2 2/20 0.49
S1PR1 P21453 1/20 0.48
MAPT P10636 1/20 0.48
HTT P42858 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7804281 1.00 LMNA (0.56) LMNACYP2D6ADRB2ADRB1ADRB3
SCHEMBL1496614 0.94 LTA4H (0.62) LMNACYP2D6ADRB2ADRB1ADRB3
SCHEMBL382120 0.93 PLA2G4B (0.55) LMNACYP2D6ADRB2ADRB1ADRB3
SCHEMBL9797717 0.93 PLA2G4B (0.55) LMNACYP2D6ADRB2ADRB1ADRB3
SCHEMBL9797915 0.93 PLA2G4B (0.55) LMNACYP2D6ADRB2ADRB1ADRB3
SCHEMBL6231558 0.93 PLA2G4B (0.55) LMNACYP2D6ADRB2ADRB1ADRB3
SCHEMBL21990 0.93 PLA2G4B (0.55) LMNACYP2D6ADRB2ADRB1ADRB3
SCHEMBL6032899 0.89 LMNA (0.60) LMNACYP2D6ADRB2ADRB1ADRB3
SCHEMBL11077119 0.86 CDK4 (0.54) CYP2D6ADRB2ADRB1ADRB3PLA2G4B
Phosphoric Acid SCHEMBL1347351 0.86 S1PR1 (0.60) LMNACYP2D6ADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3875550-A1 PAINT STRIPPING AGENT AND METHOD FOR STRIPPING PAINT FROM OBJECTS ABL-TECHNIC Entlackung GmbH (DE) 2021-09-08 EP disclosed
US-9006312-B2 Composite compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2015-04-14 US disclosed
US-8937145-B2 Epoxy resin compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2015-01-20 US disclosed
US-20120289624-A1 COMPOSITE COMPOSITIONS BLUE CUBE IP LLC 2012-11-15 US disclosed
US-20120238709-A1 EPOXY RESIN COMPOSITIONS BLUE CUBE IP LLC 2012-09-20 US disclosed
CN-101374791-B Method for producing optically active alcohol compound SUMITOMO CO LTD 2012-07-18 CN disclosed
CN-101374792-B Method for producing optically active alcohol compound SUMITOMO CHEMICAL CO 2012-03-28 CN disclosed
US-7906667-B2 Method for producing optically active alcohol compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-15 US disclosed
US-20100234629-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-16 US disclosed
US-7728179-B2 Method for producing optically active alcohol compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-01 US disclosed
US-20090012330-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-08 US disclosed
EP-1982972-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-10-22 EP disclosed
EP-1982973-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-10-22 EP disclosed
US-6995110-B2 Complex catalyst, process for producing the complex catalyst, and process for producing alcohol derivative with the complex catalyst SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-02-07 US disclosed
WO-2005044008-A2 2 -AMINOTHIOPHENE COMPOUNDS AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2005-05-19 WO disclosed
US-20040077487-A1 Complex catalyst, process for producing the complex catalyst, and process for producing alchohol derivative with the complex catalyst SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-04-22 US disclosed
EP-1380342-A1 COMPLEX CATALYST, PROCESS FOR PRODUCING THE COMPLEX CATALYST, AND PROCESS FOR PRODUCING ALCOHOL DERIVATIVE WITH THE COMPLEX CATALYST SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2004-01-14 EP disclosed
EP-1104395-A1 STEREOSELECTIVE RING OPENING REACTIONS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2001-06-06 EP disclosed
WO-2000009463-A1 STEREOSELECTIVE RING OPENING REACTIONS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2000-02-24 WO disclosed
EP-0315748-A2 Positive-working radiation-sensitive composistion and radiation-sensitive recording material produced therefrom HOECHST AKTIENGESELLSCHAFT (DE) 1989-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012330-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND ADH1A, ADH1C, ADH5 LMNA 3411/4885CYP2D6 1044/4885ADRB2 1220/4885
US-20100234629-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND ADH1A, ADH1C, ADH5 LMNA 3091/4885CYP2D6 445/4885ADRB2 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.